Maaike Van Trimpont

In vivo stabilization of a less toxic asparaginase variant leads to a durable antitumor response in acute leukemia

A. Lavie, P. Van Vlierberghe, P. Lorenzi, 2022, Haematologica.

Cell-penetrating Alphabody protein scaffolds for intracellular drug targeting

I. Lasters, J. Desmet, S. Savvides, 2021, Science Advances.

The spleen as a sanctuary site for residual leukemic cells following ABT-199 monotherapy in ETP-ALL.

Paul D. Donovan, A. Lavie, R. Lock, 2021, Blood advances.

Novel Insights on the Use of L-Asparaginase as an Efficient and Safe Anti-Cancer Therapy

A. Lavie, P. Van Vlierberghe, S. Goossens, 2022, Cancers.

Cyclin D2 overexpression drives B1a-derived MCL-like lymphoma in mice

G. Berx, A. Marchand, P. Van Vlierberghe, 2021, The Journal of experimental medicine.

Cross-talk between GLI transcription factors and FOXC1 promotes T-cell acute lymphoblastic leukemia dissemination

Jingjing Liu, Koon-Kiu Yan, A. D. Dei Tos, 2020, Leukemia.